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Abstract
Resurgent sodium currents likely play a role in modulating neuronal excitability. Here we studied 
whether protein kinase C (PKC) activation can increase resurgent currents produced by the human 
sodium channel hNav1.7. We found that a PKC agonist significantly enhanced hNav1.7-mediated 
resurgent currents and this was prevented by PKC antagonists. The enhancing effects were 
replicated by two phosphorylation-mimicking mutations and were prevented by a 
phosphorylation-deficient mutation at a conserved PKC phosphorylation site (Serine 1479). Our 
results suggest that PKC can increase sodium resurgent currents through phosphorylation of a 
conserved Serine residue located in the domain III–IV linker of sodium channels.
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Introduction
Resurgent currents are generated by a subset of voltage-gated sodium channels (VGSC) 
during repolarization of the action potential (AP) when sodium channels are normally 
thought to be inactivated and refractory to activation (Raman and Bean 1997). They can 
provide a depolarizing drive for AP regeneration, and therefore likely contribute to 
modulating neuronal excitability (Raman and Bean 2001). Sodium channel mutations 
associated with multiple diseases including paroxysmal extreme pain disorder (PEPD), 
paramyotonia congenita, and long QT-3 dramatically increase resurgent currents and 
neuronal excitability when expressed in dorsal root ganglion (DRG) neurons (Jarecki et al., 
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2010). Recently we found that resurgent currents in DRG neurons were significantly 
enhanced by a group of inflammatory mediators including PGE2, Bradykinin, ATP, 
histamine, and serotonin (Tan et al., 2014). These inflammatory mediators are known to 
increase excitability of DRG neurons through activation of cell signaling pathways. 
Previously it was shown that phosphorylation of some component of the sodium channel 
complex substantially modulated resurgent currents in cerebellar Purkinje neurons (Grieco 
et al., 2002). Protein kinase C (PKC) can be activated by several of the inflammatory 
mediators listed above (Seabrook et al., 1997; Wang et al., 2007) and therefore we 
postulated that PKC activation might modulate resurgent sodium currents.
In the current report, we first tested if PKC activation can increase resurgent currents 
generated in the human sodium channel hNav1.7 expressed in human embryonic kidney 293 
(HEK293) cells. We found that the PKC agonist Phorbol 12-myristate 13-acetate (PMA) 
significantly enhanced hNav1.7-mediated resurgent currents and that this effect was 
prevented by the PKC antagonists Bisindolylmaleimide I (Bis I) or Chelerythrine. We 
further tested if a conserved PKC phosphorylation site, S1479 is involved in the enhancing 
effects of PMA on resurgent currents utilizing site-directed mutagenesis. We found that the 
enhancing effects were mimicked by two phosphorylation-mimicking mutations and were 
prevented by a phosphorylation-deficient mutation. Furthermore, we found that PMA 
significantly increased resurgent currents generated by a hNav1.7 mutant that is associated 
with PEPD. Our results suggest that PKC can increase sodium resurgent currents through a 
conserved Serine residue located in the domain III–IV linker of sodium channels.
Materials and Methods
Cell lines
stably transfected cell lines were prepared as described before (Theile and Cummins, 2011). 
Briefly, mutations of hNav1.7 including S1479D, S1479E, S1479A, and M1627K were 
generated using the QuikChange II XL site-directed mutagenesis kit (Agilent Technologies, 
Santa Clara, CA). DNAs of wild-type (WT) and mutations of hNav1.7 were transfected into 
HEK293 cells using the calcium phosphate technique. Stable cell lines expressing WT and 
mutant hNav1.7 were selected after 3 weeks of incubation with G418. Stocks of stable cell 
lines were frozen at −80°C.
Cell culture
HEK293 cells expressing WT or mutant hNav1.7 were thawed and grown in petri dishes 
until they were plated on glass coverslips coated with poly-D-lysine and laminin. Cells were 
incubated in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine 
serum at 37°C in a humidified 95% air and 5% CO2 incubator.
Voltage clamp
Whole-cell patch clamp recordings were conducted in voltage-clamp mode at room 
temperature (about 22°C) using a HEKA EPC-10 amplifier. Data were acquired on a 
Windows based Pentium IV computer using the Pulse program (version 8.80; HEKA 
Elektronik). Fire polished electrodes (0.8–1.2 MΩ) were fabricated from 1.7-mm capillary 
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glass using a Sutter P-97 puller (Novato), and the tips were coated with sticky wax 
(KerrLab) to minimize capacitive artifacts and enable increased series resistance 
compensation. The standard electrode solution consisted of 140 mM CsF, 10 mM NaCl, 1.1 
mM EGTA, and 10 mM HEPES, pH 7.3. The standard extracellular bathing solution 
contained 140 mM NaCl, 3 mM KCl, 1 mM MgCl2, 1 mM CaCl2, and 10 mM HEPES, pH 
7.3.
Cells on glass coverslips were transferred to a recording chamber containing 250 μl bathing 
solution. Series resistance errors were compensated by 80% or more. Leak currents were 
linearly canceled by digital P/–5 subtraction. Cells were held at a membrane potential of –
100 mV. Membrane currents were sampled at 20 kHz, filtered online at 5 kHz, and further 
filtered at 1 kHz digitally in Pulsefit. Whole-cell current recordings were started 3 minutes 
after the whole-cell configuration had been established to allow adequate time for the 
electrode solution and cytoplasmic milieu to equilibrate. Resurgent currents were assayed 
with a 2-step protocol that initially depolarized the membrane to +30 mV for 20 ms before 
testing for inward resurgent sodium currents by hyperpolarizing the membrane potential in –
5-mV increments from 5 mV to –85 mV, for 50 ms, before stepping to −80 mV. Each 
voltage step was repeated three times and averaged to accurately record resurgent currents at 
each voltage. 200 μM β4 peptide (a peptide mimicking the C-terminal segment of the 
sodium channel β4 subunit, KKLITFILKKTREK-OH) was included in the pipette solution. 
The peak transient current-voltage (IV) relationship was tested using a series of depolarizing 
voltage steps in 5-mV increments ranging from −100 to +55 mV. Steady-state inactivation 
was tested by a test pulse to 0 mV from a series of 500 ms pre-holding pulses in 5-mV 
increments ranging from −130 to −5 mV.
PMA or control DMSO (0.1% v/v) was pretreated for 5 min in the recording chamber before 
a patch trial started. Bis I and Chelerythrine were pretreated for 15 min in culture and kept in 
the recording chamber. All three chemicals were dissolved in DMSO at 1 mM and were 
used at a final concentration of 1 μM.
Data analysis
Experimental data were analyzed using Pulsefit (version 8.80; HEKA Elektronik), Origin 
(version 8.0; OriginLab Corp.), and Microsoft Excel software programs. Averaged data were 
presented as Mean ± standard error. One way ANOVA with post hoc Tukey test, and 
Student t test were used to test the significance of statistical data. The significance levels 
were set at P<0.05 and P<0.01.
Resurgent currents were first identified by their kinetics and gating properties. Compared to 
fast tail currents which have a linear IV relationship, resurgent currents develop and decay 
much more slowly, and have a “V” shaped IV curve that peaks around −35 mV. Currents 
showing both criteria were classified as resurgent currents. Currents that did not display both 
properties were excluded from analysis. To compare the resurgent currents among different 
mutant or treatment groups, ratio resurgent currents were calculated by normalizing peak 
resurgent currents to the peak transient current triggered by a test pulse to 0 mV from a 500 
ms holding pulse of −110 mV.
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Voltage-gating properties including steady-state activation and inactivation, and kinetic 
properties including time-dependent activation and inactivation were analyzed in Pulsefit. 
Half activation or inactivation voltage (V0.5), and time constants for activation (τm) and 
inaction (τh) were obtained.
Results
As shown in Fig.1, resurgent currents from hNav1.7 expressed in HEK 293 cells were 
recorded using the resurgent current protocol which first inactivated peak transient sodium 
current by a voltage step to +30 mV for 20 ms, and then repolarized cells to a series of 
voltage stimuli to test for the re-opening of sodium channels. To test whether PKC 
activation can modulate resurgent currents generated by hNav1.7, we used a PKC agonist 
PMA and two PKC antagonists Bis I and Chelerythrine (Herbert et al., 1990; Toullec et al., 
1991). We found that 1μM PMA significantly increased peak resurgent current amplitude 
(Fig.1A,B,E) without changing the transient current density (measured with the steady-state 
inactivation protocol by the −110 to 0 mV voltage step; 289±39 vs. 273±59 pA/pF, Control 
vs. PMA). PMA treatment augmentation of hNav1.7 resurgent current amplitude was 
prevented by pretreatment with the PKC antagonists Bis I or Chelerythrine at the 
concentration of 1 μM (Fig 1) (Thomas et al., 2004; Harmati et al., 2011). In addition, 1μM 
PMA also significantly shifted the peak voltage, the voltage where peak resurgent current 
was measured (from −39 mV for control to −33 mV for PMA treated; Suppl Fig 1). 
However, only Bis I but not Chelerythrine prevented this shift (Suppl Fig 1). Overall the 
results showed that PKC activation increased the amplitude of resurgent currents mediated 
by hNav1.7.
It has been reported that there are three conserved PKC phosphorylation sites located in 
intracellular loops of voltage-gated sodium channels (West et al., 1991; Cantrell et al., 
2002). Two sites are located at the domain I-II linker along with several PKA sites (Cantrell 
et al., 2002). The third site is located at the domain III–IV linker and is close to the IFM 
inactivation gate (West et al., 1991). Because the proposed mechanism for resurgent current 
activation is open-channel block induced by the intracellular C-terminal loop of the sodium 
channel β4 subunit (Grieco et al., 2005), and mutations or toxins that interfere with sodium 
channel fast inactivation can increase resurgent currents (Klinger et al., 2012; Lewis and 
Raman, 2013), we suspected that the conserved phosphorylation site in the domain III–IV 
linker might be involved in the effects of PMA on hNav1.7-produced resurgent currents. To 
examine this possibility, we mutated this phosphorylation site S1479 to either aspartate or 
glutamate (S1479D and S1479E) to mimic the phosphorylated state, and to alanine 
(S1479A) to prevent phosphorylation. We then constructed stably transfected HEK 293 cell 
lines for WT and mutant hNav1.7 and compared their ability to generate resurgent currents. 
We found that one phosphorylation-mimicking mutant S1479D dramatically increased 
hNav1.7-generated resurgent currents (Fig.2ABF). The other phosphorylation-mimicking 
mutant S1479E also showed a trend toward increased resurgent current compared to WT 
channel (P<0.1, Tukey test, one way ANOVA) (Fig.2ACF). The phosphorylation-deficient 
mutant S1479A did not significantly affect resurgent currents (Fig.2D), but prevented the 
effects of PMA on resurgent currents (Fig.1 & Fig.2 DEF). There were no significant 
differences in the peak voltage of resurgent currents between WT and mutants 
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(Supplemental Fig. 1). The above results suggested that phosphorylation of S1479 in 
hNav1.7 by PKC can increase resurgent currents.
Our lab previously reported that Nav1.7 mutations associated with PEPD enhanced 
resurgent currents in HEK 293 cells (Theile et al., 2011). We tested whether PKC activation 
can further enhance resurgent currents generated by a PEPD mutant, M1627K. We found 
that the PKC agonist PMA significantly enhanced resurgent currents produced by M1627K 
mutant Nav1.7 channels (Fig.3). The results suggest that PKC and M1627K might enhance 
hNav1.7-produced resurgent currents through mechanisms that are at least partially additive.
It has been shown that PKC activation can modulate classic current properties of sodium 
channels (Vijayaragavan et al., 2004; Chen et al., 2006). To test how the classic transient 
hNav1.7 current properties may be modulated by PKC phosphorylation, we examined the 
effects of PKC agonist and antagonists, and S1479 mutations on current properties in the 
absence of intracellular β4 peptide (Table 1, Supplemental Fig. 2). We found that PKC 
agonist PMA and S1479 phosphorylation-mimicking mutants caused similar changes in 
transient current properties of hNav1.7 (Table 1, Supplemental Fig. 2). Both PMA and 
S1479E significantly shifted the half activation potential to more depolarized potentials; 
both PMA and S1479D significantly shifted the half inactivation potential to more 
depolarized potentials; and both PMA and the S1479D significantly increased the time 
constants for current inactivation. The effects of PMA on these transient current properties 
were prevented by PKC antagonists Bis I or Chelerythrine (Table 1, Supplemental Fig. 2). 
The phosphorylation-deficient mutant S1479A did not cause any changes in regular current 
properties (Table 1, Supplemental Fig. 2). On the other hand, slope factors for current gating 
voltage-dependence were only modulated by S1479E compared to PMA (Table 1, 
Supplemental Fig. 2). The results suggested that PKC modulated transient current properties 
through phosphorylation of S1479 in hNav1.7 channels.
Discussion
Researchers have shown that sodium resurgent currents can be modulated by a variety of 
factors such as sodium channel mutation (Jarecki et al., 2010; Lewis and Raman, 2013), 
sodium channel β4 subunit (Bant and Raman, 2010), natural toxins (Klinger et al., 2012) and 
chemotherapy drugs (Sittl et al., 2012). Resurgent currents can be up-regulated by 
inflammatory mediators associated with pain hypersensitivity (Tan et al., 2014) or in 
epilepsy models (Hargus et al., 2011). However to our knowledge, there is only one 
published study investigating the possible roles of cell signaling in modulating resurgent 
currents (Grieco et al., 2002). In this study, the authors found that intracellular application of 
alkaline phosphatase abolished resurgent currents in cerebellar Purkinje neurons. The results 
indicated that constitutive phosphorylation of some part of the sodium channel complex is 
necessary for producing resurgent currents in Purkinje neurons. In the current report, we 
showed that PKC activation by PMA increased resurgent currents of hNav1.7 in HEK193 
cells. These effects were blocked by PKC antagonists Bis I and Chelerythrine. Our results 
show for the first time that a specific protein kinase, PKC, can modulate sodium resurgent 
currents.
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We recently showed that a group of inflammatory mediators including PGE2, Bradykinin, 
ATP, histamine, and serotonin can increase resurgent currents in DRG neurons (Tan et al., 
2014). Several of these inflammatory mediators can activate the PKC pathway, either 
directly or indirectly (Seabrook et al., 1997; Wang et al., 2007). The current finding of PKC 
increasing resurgent currents of hNav1.7 in HEK293 cells suggest that PKC activation might 
contribute to the effects of inflammatory mediators on resurgent currents in DRG neurons. 
However, because the cell environment and sodium channels isoforms can affect generation 
of resurgent currents in endogenous neurons (Raman and Bean, 1997; Cummins et al., 
2005), further studies need to be conducted to fully test this possibility. It would be 
interesting to test if other protein kinases contribute to the enhancing effects of inflammatory 
mediators on resurgent currents in DRG neurons. For example, ERK1/2 activation was 
found to directly phosphorylate Nav1.7 and an ERK1/2 inhibitor caused a depolarizing shift 
in the activation curve of Nav1.7 and decreased excitability of DRG neurons (Stamboulian 
et al., 2010).
Three conserved PKC phosphorylation sites in sodium channels have been reported (West et 
al., 1991; Cantrell et al., 2002). Two of them are located in the domain I–II loop; the other 
one is located in the domain III–IV loop close to IFM inactivation gate. In the current study, 
we found that two phosphorylation-mimicking mutations at the conserved phosphorylation 
site in the domain III–IV loop, which is S1479 in hNav1.7, increased or showed a trend 
increase of resurgent currents. Furthermore, a phosphorylation-deficient mutant at the same 
site (S1479A) prevented the increasing effects of PMA on resurgent currents. The results 
suggest PKC activation can increase resurgent current of hNav1.7 through a conserved 
phosphorylation site in the domain III–IV loop. The current study did not mutate the other 
two phosphorylation sites or test the effects of PKC activation on resurgent currents in the 
S1479D and S1479E mutants. Therefore, a contributing role of other phosphorylation sites 
to the enhancing effects of PKC activation cannot be fully excluded.
PKC has been shown to modulate current properties of sodium channels expressed in 
different tissues. PKC activation reportedly slowed time-dependent inactivation in the brain 
sodium channel Nav1.2 through the conserved phosphorylation site in the domain III–IV 
loop (West et al., 1991). PKC caused a hyperpolarizing shift of steady-state inactivation in 
cardiac (Nav1.5) and skeletal (Nav1.4) sodium channel with different mechanisms 
(Bendahhou et al., 1995; Qu et al., 1996): the effects on Nav1.5, but not for Nav1.4, are 
dependent on the conserved phosphorylation site in domain III–IV loops. PKC activation 
resulted in a depolarizing shift of steady-state activation in peripheral sodium channel 
isoforms Nav1.7 and Nav1.8 in Xenopus oocytes (Vijayaragavan et al., 2004). In the current 
study using HEK293 cells, we found that PKC activation by PMA significantly shifted 
gating curves of both steady-state activation and inactivation to more depolarized potentials, 
and slowed time-dependent current activation and inactivation. We further found that 
phosphorylation-mimicking mutants of S1479 showed similar effects on gating and kinetic 
properties of hNav1.7. The results reproduce some of the previous findings of slowing 
inactivation in Nav1.2 (West et al., 1991) and shifting the steady-state activation of Nav1.7 
to more depolarized potentials (Vijayaragavan et al., 2004). Toxins that slow inactivation 
(Klinger et al., 2012) and some disease mutations that slow inactivation (Jarecki et al., 2010) 
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can enhance resurgent sodium currents in neurons. Although PKC phosphorylation of S1479 
does not seem to be absolutely necessary for the generation of resurgent currents, PKC 
slowing of inactivation can increase resurgent current amplitudes and, as with toxin and 
disease mutation induced resurgent currents, this is likely to contribute to increased neuronal 
excitability.
PKC was reported to have diverse effects on Nav1.7 in terms of transient current density or 
protein expression in different tissue. In in vitro cultured DRG neurons, PKC was found to 
increase Nav1.7 expression (Chattopadhyay et al., 2008). One the other hand, PKC 
decreased Nav1.7 current or expression in Xenopus oocytes (Vijayaragavan et al., 2004) or 
adrenal chromaffin cells (Wada et al., 2004). In the current study using HEK 293 cells, we 
did not see a significant change in transient current density caused by PKC activation. These 
results suggest PKC can have complex effects on Nav1.7 current or channel expression in 
different tissues and conditions.
In summary, while phosphorylation of S1479 is not necessary for Nav1.7 resurgent current 
generation, it can substantially increase Nav1.7 resurgent current amplitude. As this site is 
conserved in Nav1.1-Nav1.8, we predict that PKC is likely to modulate resurgent currents in 
multiple isoforms through phosphorylation of this conserved serine.
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Abbreviations
PEPD Paroxysmal extreme pain disorder
VGSC Voltage-gated sodium channels
Bis I Bisindolylmaleimide I
PMA Phorbol 12-myristate 13-acetate
Che Chelerythrine
AP Action potential
DRG Dorsal root ganglion
PKC Protein kinase C
HEK293 Human embryonic kidney 293
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Highlights
• PKC activation increased resurgent currents produced by hNav1.7
• Phosphorylation-mimicking mutations at S1479 increased resurgent currents
• Phosphorylation-deficient mutation prevented increasing effects of PKC
• These data suggest PKC increases resurgent currents through S1479 
phosphorylation
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Fig.1. Increase of hNav1.7 resurgent currents by PKC activation
Representative resurgent currents were recorded from HEK 293 cells expressing hNav1.7 in 
the presence of 200 μM β4 peptide in the patch pipettes. The currents were recorded using 
the voltage protocol shown in Fig.1F. Note that currents are scaled to reflect the ratio 
resurgent currents. The ratio resurgent currents were calculated by normalizing peak 
resurgent currents to peak transient currents recorded in the same cells. (A & B) PMA 
significantly increased resurgent currents compared to control. (C & D) PKC antagonists 
Bisindolylmaleimide I (Bis I) or Chelerythrine (Che) prevented the increasing effects of 
PMA. (E) Summary of ratio resurgent current. The data were presented as Means ± 
Standard Errors. *, P<0.05, PMA vs. Control (One way ANOVA, Tukey test).
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Fig.2. Increase of hNav1.7 resurgent currents by phosphorylation-mimicking mutations
Representative resurgent currents were recorded from HEK 293 cells expressing WT and 
mutant hNav1.7 channels in the presence of 200 μM β4 peptide in the patch pipettes. The 
currents were recorded using the voltage protocol shown in Fig.1F. Note that currents are 
scaled to reflect the ratio resurgent currents. The ratio resurgent currents were calculated by 
normalizing peak resurgent currents to peak transient currents recorded in the same cells. 
One phosphorylation-mimicking mutant S1479D dramatically increased resurgent currents 
compared to control. The other phosphorylation-mimicking mutant S1479E showed a trend 
increase in resurgent current compared to WT (P<0.10). (D & E) a phosphorylation-
deficient mutant (S1479A) did not change resurgent currents by itself. However, S1479A 
prevented the increasing effects of PMA on resurgent currents shown in Figure 1. (F) 
Summary of ratio resurgent current. The data were presented as Means ± Standard Errors. 
**, P<0.01 (One way ANOVA, Tukey test).
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Fig.3. Increase of PEPD mutant resurgent currents by PMA
Representative resurgent currents were recorded from HEK 293 cells expressing a PEPD 
mutant of hNav1.7 (M1627K) in the presence of 200 μM β4 peptide in the patch pipettes. 
The currents were recorded using the voltage protocol shown in Fig.1F. Note that currents 
are scaled to reflect the ratio resurgent currents. The ratio resurgent currents were calculated 
by normalizing peak resurgent currents to peak transient currents recorded in the same cells. 
(A & B) PMA increased resurgent currents compared to control M1627K. (C) Summary of 
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ratio resurgent current. The data were presented as Means ± Standard Errors. *, P<0.05 
(Student t test).
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